Merck has been eliminating thousands of jobs and trying to boost demand of existing products to overcome the revenue loss from Singulair, which began facing competition from cheaper copies last year. Photographer: JB Reed/Bloomberg
Merck has been eliminating thousands of jobs and trying to boost demand of existing products to overcome the revenue loss from Singulair, which began facing competition from cheaper copies last year. Photographer: JB Reed/Bloomberg
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=550891789&utmp=%2Fphoto%2F2013-02-01%2Fmerck-forecasts-2013-profit-will-decline-as-generics-cut-results&utmhn=10.248.67.17&utmac=UA-11413116-12&utmhid=252299805)